-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Bone Biologics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
- Bone Biologics Corp Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$1.52M, a 1.82% increase year-over-year.
- Bone Biologics Corp Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$4.11M, a 54% increase year-over-year.
- Bone Biologics Corp annual Net Income (Loss) Attributable to Parent for 2024 was -$4.11M, a 54% increase from 2023.
- Bone Biologics Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$8.95M, a 503% decline from 2022.
- Bone Biologics Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$1.48M, a 7.83% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)